True North Therapeutics - Ownership and Business Overview

Life ScienceCompany

True North Therapeutics Ownership

Who owns True North Therapeutics?

True North Therapeutics is owned by Bioverativ. It was acquired on May 23, 2017.

True North Therapeutics Business Overview

Where is True North Therapeutics headquartered?

True North Therapeutics is headquartered in San Francisco, California.

What sector is True North Therapeutics in?

True North Therapeutics is a life science company.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 226 by strategics.

True North Therapeutics, Inc.

951 Gateway Blvd.,
San Francisco, California 94080
United States,
(650) 872-4700
www.truenorthrx.com

True North Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class product candidates for complement-mediated diseases. The company’s lead product candidate, TNT009, is designed to selectively inhibit a target in the classical complement pathway. True North’s antibody drug development is focused on the treatment of certain rare diseases mediated by the complement system.


 Subscribe to unlock this and 208,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.